Therefore, we studied the phoshorylation status of Lyn, Fyn, and Src at both regulatory sites in platelets of dasatinib or nilotinib treated CML patients. This evidence concerns the gene FYN and chronic myelogenous leukemia, BCR-ABL1 positive.